Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

Global Vasculitis Therapeutics Pipeline Review 2016 - Research and Markets

Research and Markets
Posted on: 25 Aug 16

Research and Markets has announced the addition of the "Vasculitis - Pipeline Review, H2 2016" drug pipelines to their offering.

This report provides comprehensive information on the therapeutic development for Vasculitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Vasculitis and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. Vasculitis Overview
  3. Therapeutics Development
  4. Pipeline Products for Vasculitis - Overview
  5. Pipeline Products for Vasculitis - Comparative Analysis
  6. Vasculitis - Therapeutics under Development by Companies
  7. Vasculitis - Therapeutics under Investigation by Universities/Institutes
  8. Vasculitis Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Vasculitis - Products under Development by Companies
  13. Vasculitis - Products under Investigation by Universities/Institutes
  14. Vasculitis - Companies Involved in Therapeutics Development
  • AnGes MG, Inc.
  • ChemoCentryx, Inc.
  • Cipla Ltd.
  • Coherus BioSciences, Inc.
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline Plc
  • Hemostemix Ltd
  • Johnson & Johnson
  • K-Stemcell Co., Ltd.
  • Panacea Biotec Limited
  • Pfizer Inc.
  • Sandoz International GmbH
  • Teijin Pharma Limited

For more information about this drug pipelines visit

Related Topics: Cardiovascular Drugs , Immune Disorders Drugs

View source version on

Business Wire

Last updated on: 25/08/2016

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.